- Stem cell charity Anthony Nolan and the Sickle Cell Society are calling on NICE (the National Institute for Health and Care Excellence) to reconsider its draft decision to reject…
- What is HLA? The HLA family of genes encode proteins that form part of our immune system and are critical in allowing it to distinguish between ‘self’ (our own cells)…
- Introduction Leading accounting and business advisory firm RSM and RSM UK Foundation have supported Anthony Nolan for 13 years, and they have been instrumental in the…
- What are we doing? Anthony Nolan has created a policy and its first environmental sustainability strategy. These provide a framework and measurable goals against which…
- Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the enormous potential of cord blood as a starting material in research to help…
- Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the importance of where starting materials come from and how the Anthony Nolan…
- The new drug delivery system is made up of three parts: An anti-cancer drug – The scientists use antibodies that target a protein called PD-1 (programmed cell death…
- In this blog, some of our patients talk about how post-transplant complications with their eyes, including graft vs host disease (GvHD), have impacted their daily lives and…
- Here, Anthony Nolan’s Chief Executive, Henny Braund, gives an overview of current and emerging treatments for blood cancer and the developments needed to give patients the best…
- Ensuring care has the patient at the centre is a key aim for the NHS and something we’re particularly interested in at Anthony Nolan. Our post-transplant care pathway sets out one…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.